Other products of microbial translocation including iFABP, a marker of gut permeability (Cox et al., 2017), sCD14 (Shitole et al., 2019), LBP (Sun et al., 2010; Cox et al., 2017; Sakura et al., 2017), and EndoCAb (Barengolts et al., 2019) are also associated with pathology in T2DM. Here, FABP2 is linked to type 2 diabetes mellitus.